Minimally invasive surgeries (MISs) are performed In order to lessen the stress on the body. Electrosurgical instruments, inflating systems, handheld instruments, and guidance devices are most frequently used to carry out these procedures. Almost all MIS types use handheld instruments such as sutures, forceps, graspers, spatulas, retractors, and dilators.

The minimally invasive surgical instruments market size in 2021 was USD 22.38 billion, and by 2030, it will reach USD 43.76 billion, growing at a 7.21% CAGR during the forecast period.

The market for minimally invasive surgical equipment is stimulated by the rising prevalence of chronic disorders, including arthritis, cancer, and cardiovascular diseases. By 2030, the American Heart Association (AHA) predicts that there will be 23.6 million cardiovascular disease-related deaths annually. 

Market Dynamics

Drivers

Primary factors influencing the market growth of minimally invasive surgical instruments are rising healthcare costs, a rising aging population, and an increasing rate of chronic disorders. Per the World Health Organization, chronic illnesses will account for 67% of cases by 2020, while 82% of fatalities will occur in developing nations. A significant factor influencing the market growth has been the rise of minimally invasive procedures. Due to the numerous advantages of minimally invasive surgery, including small or no incisions, brief hospital stays, less discomfort, quick recovery times, low scarring, and minimal blood loss, demand for this type of surgery is rising. The market for minimally invasive surgery equipment has grown as non-robotic minimally invasive surgery becomes increasingly popular.

Restraints

Problems, including strict government rules and expensive surgical equipment, constrain the market's development for minimally invasive surgical instruments.

Opportunity 

Due to its business-friendly climate and lax regulatory rules, the Asia-Pacific region's market for minimally invasive surgical instruments is expanding quickly. This has, in turn, attracted market leaders to invest in MIS surgical instruments in this region in the future.

Market Segmentation 

By Device

The portable devices category ruled the market for minimally invasive surgical instruments in 2022, with a market share of more than 22%. Handheld equipment used in MIS approaches works to lessen unnecessary tissue damage during surgical procedures, which speeds up patient recovery and lessens pain and side effects. The vast majority of MIS equipment is single-use only. Technology improvements and their rising application in minimally invasive procedures drive the market for portable equipment. 

By Application 

The gastrointestinal segment held the largest market share due to the rising frequency of gastrointestinal ailments in young, adult, and elderly populations worldwide. The gastrointestinal system of the body, which comprises the alimentary canal, digestive tract, and gastrointestinal tract, is associated with Irritable Bowel Syndrome (IBS), Crohn's disease, peptic ulcers, and other illnesses.

By End-Use

In 2021, the hospital segment led the market with 67% of the revenue share due to the rising number of hospitals around the world. Additionally, governments all around the world are making efforts to develop healthcare facilities. Additionally, the market is rising as a result of the increasing prevalence of chronic diseases.

Regional Analysis 

North America was the major regional market, with a share of 44.1% in 2021, due to the rising rate of unintentional injuries and the sizable elderly population. In the United States, patients have a choice in the providers and forms of treatment. This will benefit the MIS market in North America.

 On the other hand, Asia Pacific will experience the fastest growth. Due to the growing elderly populations in China and Japan, more traffic accidents, and a burgeoning economy, MIS processes will increase in the Asia Pacific region. The strong demand for minimally invasive operations in this region is mostly due to the rise in medical tourism, primarily for aesthetic surgery.

Key Players 

· Stryker Corporation

· Medtronic plc 

· Johnson & Johnson  

· Abbott Laboratories, Inc. 

· B. Braun Melsungen AG 

· Boston Scientific Corporation 

· Smith & Nephew plc 

· CONMED Corporation 

· Zimmer Biomet Holdings, Inc. 

· HOYA Corporation 

· Becton, Dickinson, and Company 

· The Cooper Companies Inc. 

· Surgical Innovations Group plc 

· KARL STORZ SE & Co. KG 

· KLS Martin Group 

· Applied Medical Resources Corporation

· STRAUSS SURGICAL  

· Scanlan International, Inc.

· AMNOTEC International Medical GmbH 

· TROKAMED GmbH  

· Wexler Surgical 

· EndoMed Systems GmbH 

· Surgical Holdings 

The minimally invasive surgical instruments market size in 2021 was USD 22.38 billion, and by 2030, it will reach USD 43.76 billion, growing at a 7.21% CAGR during the forecast period. The desire for minimally invasive surgical instruments is growing due to the advantages of these treatments, such as fewer major operating and postoperative complications and quicker recovery times. 

Related Reports:

Food Preservatives Market Report - The global food preservatives market will witness a robust CAGR of 5%, valued at $3 billion in 2021, expected to appreciate and reach $4.65 billion by 2030, confirms Strategic Market Research.